Intuitive Surgical (ISRG): Procedure Slowdown Risks Growth Thesis

Slowing U.S. bariatric procedure growth, influenced by the rising popularity of GLP-1 drugs, along with capital budget constraints at hospitals, are presenting a complex picture for Intuitive Surgical (ISRG) investors. Despite these near-term challenges, the company has maintained an operating margin expansion for three consecutive years and its management has raised its 2026 non-GAAP gross margin forecast, while continuing investments in research and development.

Analysts remain generally optimistic about the long-term adoption of robotic-assisted surgery systems, a core belief for owning ISRG. However, the recent slowdown in U.S. procedures, particularly in deferrable and bariatric cases, directly addresses the primary near-term catalyst: the ability to sustain procedure growth. This also highlights a significant risk: hospital budget constraints and a shifting procedure mix could dampen system placements and overall utilization. The stock's recent pullback is seen as a reflection of these concerns, though not yet a fundamental alteration of the long-term adoption thesis.

Management's decision to increase its 2026 non-GAAP gross margin outlook while continuing R&D funding signals confidence in maintaining healthy unit economics amidst pressure on mix and capital budgets. This move aims to bolster high-margin recurring revenue from instruments and services. If Intuitive Surgical can sustain its margins while simultaneously expanding indications and utilization, it may mitigate some of the financial impact from reduced U.S. bariatric volumes and capital spending limitations.

However, hospital budgets and payer scrutiny remain key risks for investors to monitor. Projections indicate Intuitive Surgical could reach $15.6 billion in revenue and $4.7 billion in earnings by 2029, requiring a 12.1% annual revenue growth rate. Some optimistic forecasts suggest a fair value of $501.73, representing a 32% upside to its current price, while other analysts have seen potential for a 66% increase.